New Delhi: The Times Group ET NOW Global Business Summit 2025 will gather the world’s leading visionaries for two days of impactful conversations.
Taking place on February 15-16, 2025, at the Taj Palace in New Delhi, the summit is poised to be a platform for intellectual exchange and progressive dialogue, motivating attendees to shape a future driven by resilience, growth, and innovation.
Heralding its journey from 2015, The Times Group’s ETNow Global Business Summit has established itself as the pinnacle of strategic foresight, acclaimed as one of Asia’s foremost forums for reimagining the future of business and society. This distinguished platform unites the world’s most celebrated thought leaders, policymakers, and innovators in a shared pursuit of transformative ideas and sustainable progress.
The Times Group’s ET NOW Global Business Summit 2025 invites you to experience Asia’s premier platform for leaders and innovators.
The summit will bring together visionary leaders and trailblazers to inspire transformative ideas, spark meaningful conversations, and shape the… pic.twitter.com/lL3Dsnw85N
— The Times Group ET NOW Global Business Summit (@ETNOW_GBS) February 5, 2025
What does the future of global business look like? The Times Group’s ETNow Global Business Summit has been answering this question for years, serving as Asia’s leading platform where world leaders, innovators, and visionaries converge to shape tomorrow. Since its inception, GBS has been graced by India’s Prime Minister, Mr. Narendra Modi, and other influential global figures, igniting transformative discussions and groundbreaking ideas.
In 2025, under the theme “Evolve, Emerge, Expand,” GBS will explore the shifts redefining the global economic landscape, focusing on how nations and businesses can adapt, grow, and expand their influence in a connected world.
More than just a summit, GBS is a hub of intellectual rigour, where global changemakers come together to script a tomorrow defined by vision, collaboration, and progress.
POPULAR | Uganda launches clinical trial for Ebola Vaccine after recent outbreak
